Homepage MediVet Biologics newsroom

Melbourne Veterinarian Performs 100th MediVet ActiStem Stem Cell Treatment for Pets

Announcement posted by MediVet Biologics 28 Sep 2016

Veterinarian has treated100 pets that suffered from hip dysplasia, arthritis and more with revolutionary Stem Cell Therapy

Melbourne, Australia

Dr. Malcolm Ware owner and lead Veterinarian at The Vet Practice, with locations in Whittlesea and South Morang, performed his 100th stem cell treatment on a canine patient this month.  Dr. Ware utilizes ActiStem which incorporates adipose or fat derived stem cell treatments available through US based MediVet Biologics.

The Stem Cell treatment allows for a same day in hospital procedure while relying on autologous cells (cells from the patient).  In addition to Stem Cell Treatments Dr. Ware offers Platelet Rich Plasma or PRP a sports medicine treatment available for pets and veterinarians. 

Dr. Ware has been impressed with the medicine, “Over the course of the last five years regenerative medicine has allowed me to move beyond the standard of care when necessary. As a Veterinarian I am looking for progressive strategies that allow me to treat my patients instead of just offering standard medication.  The medicine continues to progress and MediVet Biologics is investing in new treatment strategies that allow me to diversify my medical toolbox.”

To contact for a consultation for your pet visit http://www.thevetpractice.com.au

About MediVet Biologics

MediVet Biologics is a USA based animal health biopharmaceutical company with headquarters in Lexington, KY. In 2010 MediVet Biologics launched ActiStem Therapy a treatment that allows for same day adult stem cell treatment.

In September, a randomized, placebo controlled double-blind university study  was published in the American Journal of Veterinary Research (AJVR) displaying safety and efficacy of the ActiStem treatment for osteoarthritis.  The company has initiated a secondary trial for the treatment of Atopic Dermatitis in dogs.

http://avmajournals.avma.org/doi/abs/10.2460/ajvr.77.9.940

In addition to Stem Cell treatments company has a portfolio of products including immunotherapy for canine cancer as well as other biologic treatment strategies for dogs, cats and horses.  www.medivetbiologics.com